GB0027552D0 - Anti-tumor compounds - Google Patents
Anti-tumor compoundsInfo
- Publication number
- GB0027552D0 GB0027552D0 GBGB0027552.9A GB0027552A GB0027552D0 GB 0027552 D0 GB0027552 D0 GB 0027552D0 GB 0027552 A GB0027552 A GB 0027552A GB 0027552 D0 GB0027552 D0 GB 0027552D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- tumor compounds
- tumor
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0027552.9A GB0027552D0 (en) | 2000-11-10 | 2000-11-10 | Anti-tumor compounds |
PCT/EP2001/012812 WO2002038590A1 (en) | 2000-11-10 | 2001-11-06 | Fap-alpha-activated anti-tumor compounds |
AU2002220684A AU2002220684A1 (en) | 2000-11-10 | 2001-11-06 | Fap-alpha-activated anti-tumor compounds |
UY27014A UY27014A1 (en) | 2000-11-10 | 2001-11-07 | ANTITUMORAL COMPOUNDS ACTIVATED BY FAP II |
US10/036,224 US20030232742A1 (en) | 2000-11-10 | 2001-11-09 | FAP-activated anti-tumor compounds |
ARP010105240A AR031316A1 (en) | 2000-11-10 | 2001-11-09 | ANTITUMORAL COMPOUNDS ACTIVATED BY FAP II |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0027552.9A GB0027552D0 (en) | 2000-11-10 | 2000-11-10 | Anti-tumor compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0027552D0 true GB0027552D0 (en) | 2000-12-27 |
Family
ID=9902983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0027552.9A Ceased GB0027552D0 (en) | 2000-11-10 | 2000-11-10 | Anti-tumor compounds |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR031316A1 (en) |
AU (1) | AU2002220684A1 (en) |
GB (1) | GB0027552D0 (en) |
UY (1) | UY27014A1 (en) |
WO (1) | WO2002038590A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1963537A4 (en) * | 2005-12-14 | 2009-11-11 | Ludwig Inst For Cancer Res Ltd | Method for diagnosing rheumatoid arthritis via assaying myofibroblast-like synoviocytes for fibroblast activation protein |
WO2011089216A1 (en) | 2010-01-22 | 2011-07-28 | Ascendis Pharma As | Dipeptide-based prodrug linkers for aliphatic amine-containing drugs |
WO2011089215A1 (en) | 2010-01-22 | 2011-07-28 | Ascendis Pharma As | Dipeptide-based prodrug linkers for aromatic amine-containing drugs |
EP2938360B1 (en) * | 2012-12-28 | 2019-09-11 | Cobiores NV | Minimally toxic prodrugs |
CN113967258A (en) * | 2014-06-13 | 2022-01-25 | 塔夫茨大学信托人 | FAP-activated therapeutics and uses related thereto |
US9737556B2 (en) | 2014-06-13 | 2017-08-22 | Trustees Of Tufts College | FAP-activated therapeutic agents, and uses related thereto |
US11613785B2 (en) | 2017-01-09 | 2023-03-28 | Onkosxcel Therapeutics, Llc | Predictive and diagnostic methods for prostate cancer |
CA3203072A1 (en) | 2020-12-22 | 2022-06-30 | Andrea CASAZZA | Compounds comprising a tetrapeptidic moiety |
WO2022167664A1 (en) | 2021-02-07 | 2022-08-11 | Cobiores Nv | Compounds comprising a tetrapeptidic moiety |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5866679A (en) * | 1994-06-28 | 1999-02-02 | Merck & Co., Inc. | Peptides |
EP0855910A4 (en) * | 1995-10-18 | 2000-07-05 | Merck & Co Inc | Conjugates useful in the treatment of benign prostatic hyperplasia |
US6613879B1 (en) * | 1999-05-14 | 2003-09-02 | Boehringer Ingelheim Pharma Kg | FAP-activated anti-tumour compounds |
-
2000
- 2000-11-10 GB GBGB0027552.9A patent/GB0027552D0/en not_active Ceased
-
2001
- 2001-11-06 AU AU2002220684A patent/AU2002220684A1/en not_active Abandoned
- 2001-11-06 WO PCT/EP2001/012812 patent/WO2002038590A1/en not_active Application Discontinuation
- 2001-11-07 UY UY27014A patent/UY27014A1/en not_active Application Discontinuation
- 2001-11-09 AR ARP010105240A patent/AR031316A1/en not_active Suspension/Interruption
Also Published As
Publication number | Publication date |
---|---|
WO2002038590A1 (en) | 2002-05-16 |
UY27014A1 (en) | 2002-07-31 |
AU2002220684A1 (en) | 2002-05-21 |
AR031316A1 (en) | 2003-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL145798A0 (en) | Fap-activated anti-tumor compounds | |
EP1349851A4 (en) | Compounds | |
AU2405002A (en) | Dehalogeno compounds | |
GB0019950D0 (en) | Compounds | |
GB0027552D0 (en) | Anti-tumor compounds | |
GB0027551D0 (en) | Anti-tumor compounds | |
GB0027554D0 (en) | Anti-tumor compounds | |
GB0015853D0 (en) | Compounds | |
GB0014641D0 (en) | Compounds | |
GB0005387D0 (en) | Compounds | |
GB0005370D0 (en) | Compounds | |
GB0031077D0 (en) | Compounds | |
GB0023193D0 (en) | Compounds | |
GB0021531D0 (en) | Compounds | |
GB0004053D0 (en) | Compounds | |
GB0020503D0 (en) | Compounds | |
GB0019578D0 (en) | Polysulphamated compounds | |
GB0018351D0 (en) | Compounds | |
GB0018306D0 (en) | Compounds | |
GB0015902D0 (en) | Compounds | |
GB0015863D0 (en) | Compounds | |
GB0009457D0 (en) | Compounds | |
GB0015852D0 (en) | Compounds | |
GB0014823D0 (en) | Compounds | |
GB0014652D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |